Here below are the publications (20) participated by Davide Corti using the term string sars-cov (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations).
Any wrong or incomplete data? Any missing, misplaced, unlicensed picture? Please report any abuse, inaccuracy or lack of information to info@ticinoscienza.ch

1) Increased breadth and neutralization of antibodies against SARS-CoV-2 variants after infection and vaccination: A serosurveillance study in pediatric patients of Southern Switzerland
European Journal of Pediatrics, 4 gennaio 2024

2) Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
Nature, luglio 2020

3) Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape
iScience, 20 gennaio 2023

4) SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines
Science Immunology, 10 novembre 2022

5) Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
Science, 20 ottobre 2022

6) ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies
Science, 12 agosto 2022

7) Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patients
PLoS One, 10 febbraio 2022

8) Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies
Nature, 31 agosto 2021

9) SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape
Nature, 14 luglio 2021

10) SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern
Science, 1 luglio 2021

11) Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
Cell Reports, 29 giugno 2021

12) In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains
Nature, 21 giugno 2021

13) Spread of a SARS-CoV-2 variant through Europe in the summer of 2020
Nature, 7 giugno 2021

14) Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland
The Lancet Regional Health - Europe, febbraio 2021

15) N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
Cell, 16 marzo 2021

16) Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Nature, 11 marzo 2021

17) Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
Nature Medicine, 4 marzo 2021

18) SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies
medRxiv, 15 febbraio 2021

19) Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
Cell, 28 gennaio 2021

20) Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms
Science, 20 novembre 2020
Davide Corti
is Head of Research Programs [Rif. 20700]
at Humabs Biomed / Vir (Rif. HB)
Via dei Gaggini 3 6500 Bellinzona